Evidence map›Paper›PMID 25279550›Full record

ArticlePloS one2014

Hydroxytyrosol prevents increase of osteoarthritis markers in human chondrocytes treated with hydrogen peroxide or growth-related oncogene α.

Annalisa Facchini, Silvia Cetrullo, Stefania D'Adamo, Serena Guidotti, Manuela Minguzzi, Andrea Facchini, Rosa Maria Borzì, Flavio Flamigni

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Annalisa FacchiniDipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Silvia CetrulloDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Stefania D'AdamoDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Serena GuidottiDipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy; Laboratorio di Immunoreumatologia and Rigenerazione Tissutale/Laboratorio RAMSES, Istituti Ortopedici Rizzoli, Bologna, Italy.
Manuela MinguzziDipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy; Laboratorio di Immunoreumatologia and Rigenerazione Tissutale/Laboratorio RAMSES, Istituti Ortopedici Rizzoli, Bologna, Italy.
Andrea FacchiniDipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy; Laboratorio di Immunoreumatologia and Rigenerazione Tissutale/Laboratorio RAMSES, Istituti Ortopedici Rizzoli, Bologna, Italy.
Rosa Maria BorzìLaboratorio di Immunoreumatologia and Rigenerazione Tissutale/Laboratorio RAMSES, Istituti Ortopedici Rizzoli, Bologna, Italy.
Flavio FlamigniDipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
University of Bologna · ITIstituto Ortopedico Rizzoli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxytyrosol (HT), a phenolic compound mainly derived from olives, has been proposed as a nutraceutical useful in prevention or treatment of degenerative diseases. In the present study we have evaluated the ability of HT to counteract the appearance of osteoarthritis (OA) features in human chondrocytes. Pre-treatment of monolayer cultures of chondrocytes with HT was effective in preventing accumulation of reactive oxidant species (ROS), DNA damage and cell death induced by H2O2 exposure, as well as the increase in the mRNA level of pro-inflammatory, matrix-degrading and hypertrophy marker genes, such as iNOS, COX-2, MMP-13, RUNX-2 and VEGF. HT alone slightly enhanced ROS production, but did not enhance cell damage and death or the expression of OA-related genes. Moreover HT was tested in an in vitro model of OA, i.e. three-dimensional micromass cultures of chondrocytes stimulated with growth-related oncogene α (GROα), a chemokine involved in OA pathogenesis and known to promote hypertrophy and terminal differentiation of chondrocytes. In micromass constructs, HT pre-treatment inhibited the increases in caspase activity and the level of the messengers for iNOS, COX-2, MMP-13, RUNX-2 and VEGF elicited by GROα. In addition, HT significantly increased the level of SIRT-1 mRNA in the presence of GROα. In conclusion, the present study shows that HT reduces oxidative stress and damage, exerts pro-survival and anti-apoptotic actions and favourably influences the expression of critical OA-related genes in human chondrocytes treated with stressors promoting OA-like features.

Indexed as

AgedAged, 80 and overAntioxidantsApoptosisBlotting, WesternCell ProliferationCells, CulturedChemokine CXCL1ChondrocytesHumansHydrogen PeroxideHypertrophyInflammation MediatorsMiddle AgedOsteoarthritisOxidants3,4-dihydroxyphenylethanolAntioxidantsChemokine CXCL1Hydrogen PeroxideInflammation MediatorsOxidantsPhenylethyl AlcoholReactive Oxygen SpeciesRNA, Messenger

Identifiers

PMID25279550
PMCPMC4184903
OpenAlexW1977879381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.